Discussion about this post

User's avatar
Jane James's avatar

There are always anecdotes …bear with me…

1. Myself 62 vaccinated, well. First covid infection was mild mid 2023, couple of days. Subsequent fatigue lasted 7 months limiting usual activity such as walking locally and felt 10+ years older lying on the settee a lot. Would have been off work if wasn’t retired. All resolved gradually after 6 months.

2. A friend, 20s vaccinated. Post covid (2021) it took a year before he could run again due to fatigue.

3. Another friend in 60s had other physical post covid problems, but I don’t have permission to comment.

So there is severely debilitating LC and your mathematical stats review is great.

But there is also the less severely affected post covid cohort whose reduced capacity to function is significant to them. Many may not see a doctor (I had basic bloods checked eg for hypothyroidism, all ok) and hopefully most recover in time.

This should not be dismissed, the numbers must be high and the impact upon the economy and their own and other’s well being should be counted I think. I don’t know how that can be done and clearly those with severe illness need the scrutiny and treatment prioritised.

I guess at some point it will be possible and acceptable to count the milder as well as the severe and hopefully there will be less of it by then. Maybe rating scales such as with eg knee pain (does it hurt 1-5 and does it affect daily living activities 1-5 could be used) to assess.

Not for you to sort out, but I wanted to say…

Expand full comment
Jeremy Lawrence's avatar

Excellent analysis. My one doubt is that the ONS and Household Pulse Long COVID stats are likely overestimates. Both are, I understand, self-reported data without a control group. Some common symptoms of Long COVID have high baseline incidence and prevalence in the uninfected, particularly fatigue and breathlessness. Lack of control for the baseline would inevitably lead to an overestimate of the effect of Long COVID.

This study, in non-hospitalised and mostly unvaccinated patients pre-Omicron found about 5% incidence of Long COVID-like symptoms in the infected, vs about 4% in a matched cohort of the uninfected: https://www.nature.com/articles/s41591-022-01909-w

That study is subject to its own methodological limitations. In particular, there were likely undetected infections in the control group leading to an over-estimate of the baseline incidence of symptoms. However it does illustrate the need for a well-constructed control group to separate symptoms due to Long COVID from identical symptoms occurring for other reasons.

The above argument is also made more eloquently and extensively in this article: https://ebm.bmj.com/content/early/2023/08/10/bmjebm-2023-112338

Expand full comment
10 more comments...

No posts